{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:37:27Z","timestamp":1783463847550,"version":"3.55.0"},"reference-count":16,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2016,1,30]]},"abstract":"<jats:p>Gitelman syndrome is an autosomal recessive distal renal tubular disorder caused by defective sodium chloride transporters. Biochemically, it presents with hypokalaemic metabolic alkalosis, hypomagnesaemia and hypocalciuria. It is usually managed with oral potassium supplements and potassium-sparing diuretics. We report a case of a 28-year-old woman whose condition worsened during pregnancy; she became resistant to standard management after delivery of her second child. She was managed in a specialist metabolic clinic through a comprehensive approach including perseverance with oral potassium supplement, weekly intravenous potassium and magnesium infusion, correction of vitamin D level and the offering of appropriate dietary advice; this controlled the patient's symptoms and prevented repeated hospital admissions. In this case report, we illustrate a patient's presentation and diagnosis with Gitelman syndrome, discuss triggers of exacerbation, review the relevant literature in terms of differential diagnoses and provide practical advice on the management of difficult cases in a specialist clinic.<\/jats:p>","DOI":"10.1136\/bcr-2015-212375","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T12:32:47Z","timestamp":1455712367000},"page":"bcr2015212375","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Management of a severe case of Gitelman syndrome with poor response to standard treatment"],"prefix":"10.1136","volume":"2016","author":[{"given":"Leila","family":"Koudsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanka","family":"Nikolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,2,17]]},"reference":[{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcpc1110051"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0196-24"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.3","first-page":"221","article-title":"A new familial disorder characterized by hypokalemia and hypomagnesemia","volume":"79","author":"Gitelman","year":"1966","journal-title":"Trans Assoc Am Physicians"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.4","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-22"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.5","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfu029"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.6","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-5-312"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.7","doi-asserted-by":"crossref","first-page":"396209","DOI":"10.4061\/2011\/396209","article-title":"Primary molecular disorders and secondary biological adaptations in Bartter syndrome","volume":"2011","author":"Desch\u00eanes","year":"2011","journal-title":"Int J Nephrol"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.8","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2014.57.1.1"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.9","first-page":"126","article-title":"Thyrotoxic periodic paralysis","volume":"19","author":"Lam","year":"2006","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.10","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfs126"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp688"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.12","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(86)90824-0"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.1.258"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.14","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-229"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.15","first-page":"12","article-title":"Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity","volume":"51","author":"Cal\u00f2","year":"1999","journal-title":"Clin Nephrol"},{"key":"2025042702444369000_2016.feb17_1.bcr2015212375.16","first-page":"472","article-title":"ACE2 and angiotensin 1\u20137 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications","volume":"23","author":"Cal\u00f2","year":"2010","journal-title":"J Nephrol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2015-212375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T09:44:52Z","timestamp":1745747092000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2015-212375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,17]]},"references-count":16,"alternative-id":["10.1136\/bcr-2015-212375"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2015-212375","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,17]]}}}